Functional characterization of monocarboxylic acid, large neutral amino acid, bile acid and peptide transporters, and P-glycoprotein in MDCK and Caco-2 cells

被引:37
作者
Putnam, WS
Ramanathan, S
Pan, L
Takahashi, LH
Benet, LZ
机构
[1] Univ Calif San Francisco, Sch Pharm, Dept Biopharmaceut Sci, San Francisco, CA 94143 USA
[2] Affymax Inc, Palo Alto, CA 94304 USA
关键词
monocarboxylic acid; bile acid; amino acid; peptide; transporter; P-glycoprotein; MDCK; Caco-2;
D O I
10.1002/jps.10264
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Bidirectional transport studies were conducted to determine whether substrates of five intestinal transporters showed carrier-mediated asymmetric transport across MDCK (Madin-Darby canine kidney) cell monolayers grown under standard conditions. Drug concentrations were quantitated using liquid scintillation counting, liquid chromatography/mass spectrometry/mass spectrometry, or liquid chromatography/mass spectrometry. In the presence of a pH gradient, benzoic acid exhibited net apical-to-basolateral transport, with apparent permeability ratios (apical-to-basolateral permeability/basolateral-to-apical permeability) ranging from 14 to 25. The addition of valproic acid reduced the permeability ratio by 70-90%. Cephalexin transport also exhibited net absorption in the presence of a pH gradient, with apparent permeability ratios ranging from 14 to 71, depending on growth conditions. Radiolabeled phenylalanine exhibited a low level of carrier-mediated absorption with an apparent permeability ratio of 1.8 that was reduced to 1.0 in the presence of unlabeled L-phenylalanine. Taurocholic acid did not exhibit carrier-mediated absorption. Cyclosporine and fexofenadine exhibited P-glycoprotein-mediated efflux from both MDCK and Caco-2 cells, which was more sensitive to inhibition in MDCK cells. These results suggest that although MDCK cell monolayers may be a useful model for evaluating transport by the absorptive monocarboxylic acid and peptide transporters and the efflux transporter, P-glycoprotein, they are not useful for predicting large neutral amino acid or bile acid transport in the intestine. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:2622 / 2635
页数:14
相关论文
共 46 条
[41]   TRANSCELLULAR TRANSPORT OF BENZOIC-ACID ACROSS CACO-2 CELLS BY A PH-DEPENDENT AND CARRIER-MEDIATED TRANSPORT MECHANISM [J].
TSUJI, A ;
TAKANAGA, H ;
TAMAI, I ;
TERASAKI, T .
PHARMACEUTICAL RESEARCH, 1994, 11 (01) :30-37
[42]   OVERLAPPING SUBSTRATE SPECIFICITIES AND TISSUE DISTRIBUTION OF CYTOCHROME-P450 3A AND P-GLYCOPROTEIN - IMPLICATIONS FOR DRUG-DELIVERY AND ACTIVITY IN CANCER-CHEMOTHERAPY [J].
WACHER, VJ ;
WU, CY ;
BENET, LZ .
MOLECULAR CARCINOGENESIS, 1995, 13 (03) :129-134
[43]   HMG-CoA reductase inhibitors (statins) characterized as direct inhibitors of P-glycoprotein [J].
Wang, EJ ;
Casciano, CN ;
Clement, RP ;
Johnson, WW .
PHARMACEUTICAL RESEARCH, 2001, 18 (06) :800-806
[44]   Atorvastatin transport in the Caco-2 cell model: Contributions of P-glycoprotein and the proton-monocarboxylic acid co-transporter [J].
Wu, XC ;
Whitfield, LR ;
Stewart, BH .
PHARMACEUTICAL RESEARCH, 2000, 17 (02) :209-215
[45]   Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells [J].
Yamashita, S ;
Furubayashi, T ;
Kataoka, M ;
Sakane, T ;
Sezaki, H ;
Tokuda, H .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2000, 10 (03) :195-204
[46]   Evidence for diminished functional expression of intestinal transporters in Caco-2 cell monolayers at high passages [J].
Yu, HS ;
Cook, TJ ;
Sinko, PJ .
PHARMACEUTICAL RESEARCH, 1997, 14 (06) :757-762